-
Je něco špatně v tomto záznamu ?
Palm Oil and Beta-palmitate in Infant Formula: A Position Paper by the European Society for Paediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN) Committee on Nutrition
J. Bronsky, C. Campoy, N. Embleton, M. Fewtrell, NF. Mis, K. Gerasimidis, I. Hojsak, J. Hulst, F. Indrio, A. Lapillonne, C. Molgaard, SJ. Moltu, E. Verduci, R. Vora, M. Domellöf, ESPGHAN Committee on Nutrition,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, práce podpořená grantem, systematický přehled
- MeSH
- fyziologie výživy kojenců MeSH
- gastroenterologie organizace a řízení MeSH
- kojenec MeSH
- kyselina palmitová krev MeSH
- lidé MeSH
- mateřské mléko chemie MeSH
- náhražky mateřského mléka chemie MeSH
- novorozenec MeSH
- nutriční stav MeSH
- palmitany aplikace a dávkování MeSH
- palmový olej aplikace a dávkování MeSH
- pediatrie organizace a řízení MeSH
- potravní doplňky MeSH
- společnosti lékařské MeSH
- Check Tag
- kojenec MeSH
- lidé MeSH
- mužské pohlaví MeSH
- novorozenec MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- systematický přehled MeSH
BACKGROUND: Palm oil (PO) is used in infant formulas in order to achieve palmitic acid (PA) levels similar to those in human milk. PA in PO is esterified predominantly at the SN-1,3 position of triacylglycerol (TAG), and infant formulas are now available in which a greater proportion of PA is in the SN-2 position (typical configuration in human milk). As there are some concerns about the use of PO, we aimed to review literature on health effects of PO and SN-2-palmitate in infant formulas. METHODS: PubMed and Cochrane Database of Systematic Reviews were systematically searched for relevant studies on possible beneficial effects or harms of either PO or SN-2-palmitate in infant formula on various health outcomes. RESULTS: We identified 12 relevant studies using PO and 21 studies using SN-2-palmitate. Published studies have variable methodology, subject characteristics, and some are underpowered for the key outcomes. PO is associated with harder stools and SN-2-palmitate use may lead to softer stool consistency. Bone effects seem to be short-lasting. For some outcomes (infant colic, faecal microbiota, lipid metabolism), the number of studies is very limited and summary evidence inconclusive. Growth of infants is not influenced. There are no studies published on the effect on markers of later diseases. CONCLUSIONS: There is insufficient evidence to suggest that PO should be avoided as a source of fat in infant formulas for health reasons. Inclusion of high SN-2-palmitate fat blend in infant formulas may have short-term effects on stool consistency but cannot be considered essential.
Childhood Nutrition Research Centre UCL GOS Institute of Child Health London UK
Children's Hospital Zagreb University of Zagreb School of Medicine Zagreb Croatia
Department of Clinical Sciences Pediatrics Umeå University Umeå Sweden
Department of Neonatal Intensive Care Oslo University Hospital Oslo Norway
Department of Paediatrics University Hospital Motol Prague Czech Republic
Department of Paediatrics University of Granada Spain
Leeds teaching hospitals NHS trust Leeds UK
Ospedale Pediatrico Giovanni XXIII University of Bari Bari Italy
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20025880
- 003
- CZ-PrNML
- 005
- 20201222155519.0
- 007
- ta
- 008
- 201125s2019 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1097/MPG.0000000000002307 $2 doi
- 035 __
- $a (PubMed)31022096
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Bronsky, Jiri $u Department of Paediatrics, University Hospital Motol, Prague, Czech Republic.
- 245 10
- $a Palm Oil and Beta-palmitate in Infant Formula: A Position Paper by the European Society for Paediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN) Committee on Nutrition / $c J. Bronsky, C. Campoy, N. Embleton, M. Fewtrell, NF. Mis, K. Gerasimidis, I. Hojsak, J. Hulst, F. Indrio, A. Lapillonne, C. Molgaard, SJ. Moltu, E. Verduci, R. Vora, M. Domellöf, ESPGHAN Committee on Nutrition,
- 520 9_
- $a BACKGROUND: Palm oil (PO) is used in infant formulas in order to achieve palmitic acid (PA) levels similar to those in human milk. PA in PO is esterified predominantly at the SN-1,3 position of triacylglycerol (TAG), and infant formulas are now available in which a greater proportion of PA is in the SN-2 position (typical configuration in human milk). As there are some concerns about the use of PO, we aimed to review literature on health effects of PO and SN-2-palmitate in infant formulas. METHODS: PubMed and Cochrane Database of Systematic Reviews were systematically searched for relevant studies on possible beneficial effects or harms of either PO or SN-2-palmitate in infant formula on various health outcomes. RESULTS: We identified 12 relevant studies using PO and 21 studies using SN-2-palmitate. Published studies have variable methodology, subject characteristics, and some are underpowered for the key outcomes. PO is associated with harder stools and SN-2-palmitate use may lead to softer stool consistency. Bone effects seem to be short-lasting. For some outcomes (infant colic, faecal microbiota, lipid metabolism), the number of studies is very limited and summary evidence inconclusive. Growth of infants is not influenced. There are no studies published on the effect on markers of later diseases. CONCLUSIONS: There is insufficient evidence to suggest that PO should be avoided as a source of fat in infant formulas for health reasons. Inclusion of high SN-2-palmitate fat blend in infant formulas may have short-term effects on stool consistency but cannot be considered essential.
- 650 _2
- $a potravní doplňky $7 D019587
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a gastroenterologie $x organizace a řízení $7 D005762
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a kojenec $7 D007223
- 650 _2
- $a náhražky mateřského mléka $x chemie $7 D041943
- 650 _2
- $a fyziologie výživy kojenců $7 D007227
- 650 _2
- $a novorozenec $7 D007231
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a mateřské mléko $x chemie $7 D008895
- 650 _2
- $a nutriční stav $7 D009752
- 650 _2
- $a palmový olej $x aplikace a dávkování $7 D000073878
- 650 _2
- $a palmitany $x aplikace a dávkování $7 D010168
- 650 _2
- $a kyselina palmitová $x krev $7 D019308
- 650 _2
- $a pediatrie $x organizace a řízení $7 D010372
- 650 _2
- $a společnosti lékařské $7 D012955
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 655 _2
- $a systematický přehled $7 D000078182
- 700 1_
- $a Campoy, Cristina $u Department of Paediatrics, University of Granada, Spain.
- 700 1_
- $a Embleton, Nicholas $u Newcastle Neonatal Service, Newcastle Hospitals NHS Trust and Newcastle University, Newcastle upon Tyne, UK.
- 700 1_
- $a Fewtrell, Mary $u Childhood Nutrition Research Centre, UCL GOS Institute of Child Health, London, UK.
- 700 1_
- $a Mis, Nataša Fidler $u Department of Gastroenterology, Hepatology and Nutrition, University Children's Hospital, University Medical Centre Ljubljana, Slovenia.
- 700 1_
- $a Gerasimidis, Konstantinos $u Human Nutrition, School of Medicine, Dentistry and Nursing, University of Glasgow, New Lister Building, Glasgow Royal Infirmary, Glasgow, UK.
- 700 1_
- $a Hojsak, Iva $u Children's Hospital Zagreb, University of Zagreb School of Medicine, Zagreb, Croatia.
- 700 1_
- $a Hulst, Jessie $u Department of Paediatric Gastroenterology, Erasmus MC, Sophia Children's Hospital, Rotterdam, The Netherlands.
- 700 1_
- $a Indrio, Flavia $u Ospedale Pediatrico Giovanni XXIII University of Bari, Bari, Italy.
- 700 1_
- $a Lapillonne, Alexandre $u Paris Descartes University, APHP Necker-Enfants Malades hospital, Paris, France. CNRC, Baylor College of Medicine, Houston, Texas.
- 700 1_
- $a Molgaard, Christian $u Department of Nutrition, Exercise and Sports, University of Copenhagen. Pediatric Nutrition Unit, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
- 700 1_
- $a Moltu, Sissel Jennifer $u Department of Neonatal Intensive Care, Oslo University Hospital, Oslo, Norway.
- 700 1_
- $a Verduci, Elvira $u Department of Pediatrics, San Paolo Hospital, Department of Health Sciences, University of Milan, Milan, Italy.
- 700 1_
- $a Vora, Rakesh $u Leeds teaching hospitals NHS trust, Leeds, UK.
- 700 1_
- $a Domellöf, Magnus $u Department of Clinical Sciences, Pediatrics, Umeå University, Umeå, Sweden.
- 710 2_
- $a ESPGHAN Committee on Nutrition
- 773 0_
- $w MED00010080 $t Journal of pediatric gastroenterology and nutrition $x 1536-4801 $g Roč. 68, č. 5 (2019), s. 742-760
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/31022096 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20201125 $b ABA008
- 991 __
- $a 20201222155515 $b ABA008
- 999 __
- $a ok $b bmc $g 1600025 $s 1116566
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 68 $c 5 $d 742-760 $e - $i 1536-4801 $m Journal of pediatric gastroenterology and nutrition $n J Pediatr Gastroenterol Nutr $x MED00010080
- LZP __
- $a Pubmed-20201125
